These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20630455)

  • 41. Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study.
    Onuma Y; Tanimoto S; Ruygrok P; Neuzner J; Piek JJ; Seth A; Schofer JJ; Richardt G; Wiemer M; Carrié D; Thuesen L; Dorange C; Miquel-Hebert K; Veldhof S; Serruys PW
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):634-42. PubMed ID: 20690152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can "true bifurcation lesion" actually be regarded as an independent risk factor of acute side branch occlusion after main vessel stenting?: A retrospective analysis of 1,200 consecutive bifurcation lesions in a single center.
    Chen X; Zhang D; Yin D; Li J; Zhao Z; Wang H; Yang Y; Xu B; Dou K
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():554-63. PubMed ID: 26863899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Kirtane AJ; Patel R; O'Shaughnessy C; Overlie P; McLaurin B; Solomon S; Mauri L; Fitzgerald P; Popma JJ; Kandzari DE; Leon MB
    JACC Cardiovasc Interv; 2009 Oct; 2(10):967-76. PubMed ID: 19850257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis.
    White AJ; Kedia G; Mirocha JM; Lee MS; Forrester JS; Morales WC; Dohad S; Kar S; Czer LS; Fontana GP; Trento A; Shah PK; Makkar RR
    JACC Cardiovasc Interv; 2008 Jun; 1(3):236-45. PubMed ID: 19463306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
    Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results.
    Gil RJ; Vassiliev D; Michałek A; Kern A; Formuszewicz R; Dobrzycki S; Lesiak M; Wójcik J; Kardaszewicz P; Lekston A
    Kardiol Pol; 2012; 70(1):45-52. PubMed ID: 22267425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel stenting technique for coronary artery bifurcation stenosis.
    Y-Hassan S; Lindroos MC; Sylvén C
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):903-9. PubMed ID: 19455665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II.
    Song YB; Hahn JY; Yang JH; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Lee JH; Yu CW; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Oh JH; Park JS; Gwon HC
    JACC Cardiovasc Interv; 2014 Mar; 7(3):255-63. PubMed ID: 24529936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sirolimus versus paclitaxel coronary stents in clinical practice.
    Millauer N; Jüni P; Hofmann A; Wandel S; Bhambhani A; Billinger M; Urwyler N; Wenaweser P; Hellige G; Räber L; Cook S; Vogel R; Togni M; Seiler C; Meier B; Windecker S
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):5-12. PubMed ID: 20506333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and angiographic outcomes after drug-eluting stent implantation with triple-kissing-balloon technique for left main trifurcation lesion: comparison of single-stent and multi-stent procedures.
    Kubo S; Kadota K; Sabbah M; Otsuru S; Hasegawa D; Habara S; Tada T; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    J Invasive Cardiol; 2014 Nov; 26(11):571-8. PubMed ID: 25363998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy.
    Nfor T; Ansaarie I; Gupta A; Bajwa T; Allaqaband S
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):543-9. PubMed ID: 19405161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
    Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE;
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of final kissing balloon inflation after simple stent implantation for the treatment of non-left main true coronary bifurcation lesions in patients with acute coronary syndrome.
    Kim TH; Lee HJ; Jang HJ; Kim JS; Park JS; Choi RK; Choi YJ; Shim WH; Ro YM; Yu CW; Kwon SW
    Int J Cardiol; 2014 Dec; 177(3):907-11. PubMed ID: 25453410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
    Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distal left main coronary bifurcation lesions predict worse outcome in patients undergoing percutaneous implantation of drug-eluting stents: results from the Drug-Eluting Stent for the Treatment of Left Main Disease (DISTAL) Study.
    Chen SL; Ye F; Zhang JJ; Liu ZZ; Lin S; Zhu ZS; Sun XW; Li F; Zhang AP; Chen JG; Ji QJ; Qian J; Chen F; Kwan TW
    Cardiology; 2009; 113(4):264-73. PubMed ID: 19246905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of multivessel stenting on top of percutaneous revascularization for unprotected left main disease in the drug-eluting stent era: insights from the Turin registry.
    Sheiban I; Sillano D; Biondi-Zoccai G; Moretti C; Garrone P; Lombardi P; Sciuto F; Omedè P; Iacovino C; Spina CL; Trevi GP
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):461-8. PubMed ID: 19395977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term clinical outcomes with the use of a modified provisional jailed-balloon stenting technique for the treatment of nonleft main coronary bifurcation lesions.
    Depta JP; Patel Y; Patel JS; Novak E; Yeung M; Zajarias A; Kurz HI; Lasala JM; Bach RG; Singh J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E637-46. PubMed ID: 23420654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study.
    Ormiston JA; Mahmud E; Turco MA; Popma JJ; Weissman N; Cannon LA; Mann T; Lucca MJ; Lim ST; Hall JJ; McClean D; Dobies D; Mandinov L; Baim DS
    JACC Cardiovasc Interv; 2008 Apr; 1(2):150-60. PubMed ID: 19463293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.